UPM Liver Study Group highlights opportunities to integrate hepatitis care into HIV services at PNCA 2026
Janus Ong discussed how HIV treatment hubs could integrate hepatitis B and C care, drawing on StITCH 1.0 experience.
Janus Ong, MD, MPH, speaks during a symposium at the Philippine National Convention on AIDS 2026. Photo: AIDS Society of the Philippines, Inc.
Janus Ong, MD, MPH, of the UPM Liver Study Group presented “HIV and Viral Hepatitis: Confronting a Dual Epidemic” on 28 October 2026 at the Philippine National Convention on AIDS (PNCA 2026), held at Crowne Plaza Galleria Manila in Quezon City.
Convened by the Department of Health’s Disease Prevention and Control Bureau, the Research Institute for Tropical Medicine, and the AIDS Society of the Philippines, the three-day convention drew more than 800 representatives from government and organizations across the country, according to the Quezon City Government.
Speaking in the symposium on viral hepatitis and prevention of mother-to-child transmission of HIV, Dr. Ong discussed how people living with HIV could get tested for hepatitis B and C during routine HIV visits and receive treatment and follow-up through the same service.
He drew on StITCH 1.0’s experience in Tarlac and Quezon City, where the team mapped the steps people took to get hepatitis care and identified where they faced delays or had to make extra trips. That work helped shape an approach in which frontline teams coordinate testing and follow-up, with specialist support when needed. HIV treatment hubs could adapt these practices so people have fewer visits and referrals to navigate.
Dr. Ong also discussed what coordinated care could look like during pregnancy. Offering screening for HIV, hepatitis B, and syphilis at the same antenatal visit can help people get timely treatment and connect newborns to preventive care. Across both settings, he highlighted the need for reliable access to tests and medicines, trained teams, and financing to sustain these services.